10th RSC-BMCS / SCI GPCRs in Medicinal Chemistry
Event
10th RSC-BMCS / SCI Symposium on GPCRs in Medicinal Chemistry
Dates
Wednesday 30th September, 2026 – Friday 2nd October, 2026
Place
Evotec Campus Levi-Montalcini, Verona, Italy
Important links and downloads
Social Media – #GPCRs2026
Please click here to submit an abstract
Please click here to register
Synopsis
The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to hold this 10th meeting in the series on GPCR drug discovery, which combines cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.
The meeting will consist of
• Case studies in GPCR drug discovery and development
• Structural biology advances and impact on drug design
Registration
Please click here to register.
Early Bird Registration Fees (until 10th July 2026)
**Student Member: £250
**Student Non Member: £370
*Member: £620
Non-Member: £865
Standard Registration Fees (from 11th July 2026)
**Student Member: £300
**Student Non Member: £425
*Member: £730
Non-Member: £970
*Member is a paid up member of the RSC or SCI.
**Student rates apply to undergraduate and postgraduate students only.
Abstracts
Abstract submission is now open!
Please click here to submit an abstract
Deadline for submission is Midnight (BST), Friday 10th July, 2026.
Want to become a member?
To join the RSC and qualify for discounted registration fees at all RSC, please click here.
Bursaries
The RSC-BMCS and SCI are offering a small number of bursaries to attend the meeting. Applications are open to PhD and post-doctoral applicants studying at academic institutions or non-profit institutions. Preference will be given to members of the RSC-BMCS and SCI. Bursary applications are also invited from RSC, SCI or EFMC members who are of working age, but currently unemployed and from those who may have difficulty in funding their attendance. The bursary application deadline is Friday 10th July.
Please click here to access the BMCS bursary application form.
Please click here to access the SCI bursary application form.
Exhibition/Sponsorship
Exhibition Package (£1,500) includes:
-Stand space – table and chairs
-Access to electricity and wi-fi
– Logo inclusion in pdf of delegate handbook and rolling slides and conference website
-Exhibitors promotional page in the pdf delegate handbook
-One stand personnel with access to technical sessions and poster sessions
– Attendance at the Wednesday evening social event
– Attendance at the Thursday evening winery tour and dinner
We are also seeking sponsorship from organisations. Minimum suggested sponsorship is £500. Sponsors receive:
– Logo in delegate handbook
– Logo in the rolling slides
– Web-linked logo on the event web page
Please click here to book an exhibitor/sponsor package.
Venue and Travel
Detailed travel information may be found in this Venue Guide.
Please click here to view our hotel recommendations.
Confirmed Speakers
Christa Muller, University of Bonn
György Keseru, HUN-REN TTK
Lotte Bjerre Knudsen, Aarhus University and formerly at Novo Nordisk 1989-2026
Hui Lei, Structure Therapeutics
Ekaterina Ratkova, AstraZeneca
Discovery of GLP-1R small molecule agonists: from balanced to biased
Rudolf Ganzoni, ETH
Single-Position Scaffold Modifications Tune Cannabinoid Receptor Activity by Targeting the Toggle Switch
Dorien De Vlieger, Confo Therapeutics
Discovery of a Selective Somatostatin receptor 5 (SSTR5) Antibody-based Agonist for the Treatment of Conditions of Hyperinsulinemia
Lauren Slosky, University of Minnesota
Agostino Cianciulli, Aptuit an Evotec Company
GPR39 Antagonism: a New Paradigm for the Treatment of Acute Myocardial Infarction and Coronary No Reflow
Lisa McArthur, Sygnature Discovery
Anne Valade, UCB
Glovadalen (UCB0022): Discovery and Structural understanding of D1 Receptor Positive Allosteric Modulation
Aurélien Rizk, InterAx Biotech
Sylvaine Cren, Idorsia Pharmaceuticals
Discovery and progression of first-in-class, potent, selective and orally bioavailable CXCR7 antagonist ACT-1004-1239 for the treatment of inflammatory and demyelinating diseases
Exhibitors
Sponsors
Organising Committee
Adrian Hall, UCB (Co-chair)
Caroline Low, Isomorphic Labs (Co-chair)
Daniel Jones, Nxera Pharma (Treasurer)
Andrew Williams, RSC BMCS
Fraser Cunningham, Recursion
Susanna Cremonesi, Evotec
Angela Russell, University of Oxford
Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333
E-mail